Imugene Limited IMU.AX Stock
Imugene Limited Price Chart
Imugene Limited IMU.AX Financial and Trading Overview
| Imugene Limited stock price | 0.09 AUD |
| Previous Close | 0.1 AUD |
| Open | 0.1 AUD |
| Bid | 0.1 AUD x 0 |
| Ask | 0.1 AUD x 0 |
| Day's Range | 0.1 - 0.1 AUD |
| 52 Week Range | 0.09 - 0.32 AUD |
| Volume | 12.76M AUD |
| Avg. Volume | 11.23M AUD |
| Market Cap | 616.61M AUD |
| Beta (5Y Monthly) | 2.372413 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.46 AUD |
IMU.AX Valuation Measures
| Enterprise Value | 512.56M AUD |
| Trailing P/E | N/A |
| Forward P/E | -9.6 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 49.576527 |
| Price/Book (mrq) | 3 |
| Enterprise Value/Revenue | 41.211 |
| Enterprise Value/EBITDA | -13.455 |
Trading Information
Imugene Limited Stock Price History
| Beta (5Y Monthly) | 2.372413 |
| 52-Week Change | -32.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.32 AUD |
| 52 Week Low | 0.09 AUD |
| 50-Day Moving Average | 0.12 AUD |
| 200-Day Moving Average | 0.15 AUD |
IMU.AX Share Statistics
| Avg. Volume (3 month) | 11.23M AUD |
| Avg. Daily Volume (10-Days) | 15.88M AUD |
| Shares Outstanding | 6.42B |
| Float | 5.18B |
| Short Ratio | N/A |
| % Held by Insiders | 15.40% |
| % Held by Institutions | 9.09% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7.5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -324.55% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -13.56% |
| Return on Equity (ttm) | -22.51% |
Income Statement
| Revenue (ttm) | 12.44M AUD |
| Revenue Per Share (ttm) | 0.002 AUD |
| Quarterly Revenue Growth (yoy) | -10.00000000000000000000000000000000% |
| Gross Profit (ttm) | 12.97M AUD |
| EBITDA | -38093488 AUD |
| Net Income Avi to Common (ttm) | -40429508 AUD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 161.91M AUD |
| Total Cash Per Share (mrq) | 0.03 AUD |
| Total Debt (mrq) | 187.56K AUD |
| Total Debt/Equity (mrq) | 0.09 AUD |
| Current Ratio (mrq) | 48.547 |
| Book Value Per Share (mrq) | 0.032 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41540920 AUD |
| Levered Free Cash Flow (ttm) | -34366272 AUD |
Profile of Imugene Limited
| Country | Australia |
| State | NSW |
| City | Sydney |
| Address | 4-6 Bligh Street |
| ZIP | 2000 |
| Phone | N/A |
| Website | https://www.imugene.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a research collaboration with Celularity Inc. to develop the combination of Imugene's CD19 oncolytic virus technology and Celularity's CD19 targeting allogeneic chimeric antigen receptor T-cell therapy, CyCART-19 for the treatment of solid tumors; and has a strategic collaboration with Eureka Therapeutics, Inc. Imugene Limited was incorporated in 1986 and is based in Sydney, Australia.
Q&A For Imugene Limited Stock
What is a current IMU.AX stock price?
Imugene Limited IMU.AX stock price today per share is 0.09 AUD.
How to purchase Imugene Limited stock?
You can buy IMU.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Imugene Limited?
The stock symbol or ticker of Imugene Limited is IMU.AX.
Which industry does the Imugene Limited company belong to?
The Imugene Limited industry is Biotechnology.
How many shares does Imugene Limited have in circulation?
The max supply of Imugene Limited shares is 7.39B.
What is Imugene Limited Price to Earnings Ratio (PE Ratio)?
Imugene Limited PE Ratio is now.
What was Imugene Limited earnings per share over the trailing 12 months (TTM)?
Imugene Limited EPS is -0.01 AUD over the trailing 12 months.
Which sector does the Imugene Limited company belong to?
The Imugene Limited sector is Healthcare.
Imugene Limited IMU.AX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| S&P/ASX ALL AUSTRALIAN 200 AXAT | 7776.9 AUD 5147.2 USD |
-0.37
|
— — | 7753.3 AUD 5131.58 USD | 7806.8 AUD 5166.99 USD | — - | — — |
| S&P/ASX SMALL ORDINARIES AXSO | 3055.7 AUD 2022.44 USD |
-0.94
|
— — | 3042.1 AUD 2013.44 USD | 3084.6 AUD 2041.56 USD | — - | — — |
| S&P/ASX 200 AXJO | 7758.6 AUD 5135.09 USD |
-0.38
|
— — | 7735.2 AUD 5119.6 USD | 7788.9 AUD 5155.14 USD | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| S&P/ASX 300 AXKO | 7711.3 AUD 5103.78 USD |
-0.4
|
— — | 7688.2 AUD 5088.49 USD | 7743.1 AUD 5124.83 USD | — - | — — |
- {{ link.label }} {{link}}